AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Edwards Lifesciences Corp Director's Dealing 2012

May 14, 2012

30042_dirs_2012-05-14_d331a4b3-79a1-4d1f-a311-0a5ab3f8101c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-05-11

Reporting Person: VON SCHACK WESLEY W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-11	Common Stock	A	2361.0000	$0.0000	Acquired	18115.0000	Direct
2012-05-11	Common Stock	A	473.0000	$0.0000	Acquired	18588.0000	Direct

Footnotes

F1: Reflects unvested Restricted Stock Units granted on May 11, 2012.

F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.

F3: Reflects unvested Restricted Stock granted on May 11, 2012.